Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133479) titled 'Prospective Clinical Study on the Efficacy and Safety of Triptorelin Pamoate (or Triptorelin Acetate) Microspheres for Injection in Patients with Adenomyosis' on Sept. 28.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Three Gorges University Affiliated Renhe Hospital
Condition:
Adenomyosis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-30
Target Sample Size: Observation Group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=345508
Disclaimer: Curated by HT Syndication....